Usana Health Sciences INC Form 4 insider transactions

Frederic J. Winssinger, a director at USANA Health Sciences, executed a transaction involving restricted stock units, resulting in the acquisition and disposal of common stock.

J Scott Nixon, a director at USANA Health Sciences, reported a transaction involving restricted stock units on November 2, 2024.

Director Peggie Pelosi reported the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations.

Director Gilbert A. Fuller reports transactions involving USANA Health Sciences Inc. stock, including the vesting and disposal of restricted stock units.

Director John Turman Fleming of USANA Health Sciences reports the vesting and disposal of restricted stock units.

Director Ding Xia of USANA Health Sciences reports acquisition and disposal of common stock and restricted stock units on November 2, 2024.

Paul A. Jones, Chief People Officer of USANA Health Sciences, reported selling 6,266 shares of common stock on August 13, 2024.

Director Gilbert A Fuller sold 674 shares of USANA Health Sciences Inc. on August 7, 2024, at a price of $39.6935 per share.

Director Timothy Wood reports the vesting and disposal of restricted stock units in USANA Health Sciences.

Director Frederic J Winssinger exercised stock options in USANA Health Sciences, acquiring 674 shares of common stock on August 2, 2024.

Director Nixon J Scott of USANA Health Sciences reports the vesting and disposal of restricted stock units on August 2, 2024.

Peggie Pelosi, a director at USANA Health Sciences, reported the vesting and disposal of restricted stock units on August 2, 2024.

Director Gilbert A. Fuller reports a transaction involving USANA Health Sciences Inc. stock, including the vesting of restricted stock units.

Director John Turman Fleming of USANA Health Sciences reports the vesting and subsequent disposal of restricted stock units.

Director Ding Xia of USANA Health Sciences reports acquisition and disposal of common stock and restricted stock units.

John Turman Fleming, a director of USANA Health Sciences, sold 1,000 shares of common stock at a price of $44.43 on July 31, 2024.

Peter Benedict, Chief Information Officer of USANA Health Sciences Inc, reports the acquisition of 2,391 restricted stock units.

USANA Health Sciences CEO Jim Brown reports the acquisition and disposal of common stock and restricted stock units on July 24, 2024.

Myron Wentz, a director and 10% owner of USANA Health Sciences, sold shares of common stock in two transactions on June 12 and June 14, 2024.

Myron Wentz, a director and 10% owner of USANA Health Sciences, indirectly disposed of 3,700 shares of common stock through Gull Global Limited on June 7, 2024.

Paul A. Jones, Chief People Officer of USANA Health Sciences, sold 2,714 shares of common stock at a price of $48.6601 per share on May 22, 2024.

USANA Health Sciences' Chief Financial Officer, IIEKKING G DOUG, sold 5,198 shares of common stock on May 7, 2024, at a weighted average price of $44.7627.

Director Gilbert A Fuller of USANA Health Sciences Inc. sold 490 shares of common stock on May 7, 2024, at a weighted average price of $44.589 per share.

Daniel A. Macuga, Chief Communications Officer of USANA Health Sciences, sold 3,791 shares of common stock at an average price of $47.1424 on May 2, 2024.

Director Timothy E. Wood reports acquisition of 2,697 restricted stock units in USANA Health Sciences, vesting quarterly over the next year.

Director Peggie Pelosi acquired 2,697 restricted stock units in USANA Health Sciences, according to a recent SEC filing.

J Scott Nixon, a director at USANA Health Sciences, acquired 2,697 restricted stock units on May 2, 2024, according to a Form 4 filing with the SEC.

Director John Turman Fleming acquired 2,697 restricted stock units in USANA Health Sciences on May 2, 2024, according to a Form 4 filing.

Director Frederic J. Winssinger acquired 2,697 restricted stock units in USANA Health Sciences Inc. on May 2, 2024.

Gilbert A. Fuller, a director of USANA Health Sciences, acquired 2,697 restricted stock units on May 2, 2024, according to a Form 4 filing with the SEC.